Results 121 to 130 of about 14,868 (228)

Effect of <i>MYCN</i> Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma. [PDF]

JCO Precis Oncol
Matser YAH, van Kuilenburg ABP, Samim A, van Liempt LM, van Grotel M, Kraal KCJM, Dierselhuis MP, van Eijkelenburg NKA, Langenberg KPS, van Noesel MM, Molenaar J, Fiocco M, Tytgat GAM.   +12 more
europepmc   +1 more source

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies. [PDF]

Alzheimers Dement (Amst)
Donaghy PC, Greenfinch G, Petrides G, Kane J, Verberne HJ, Taylor JP, O'Brien JT, Thomas AJ, DLB Indicative Imaging Biomarker Study Group.   +8 more
europepmc   +1 more source

Stratifying risk of heart failure death and arrhythmic events: a ¹²³I-meta-iodobenzylguanidine-based multinomial logistic model. [PDF]

Eur J Nucl Med Mol Imaging
Nakajima K, Doi T, Nakata T, Nakahashi T, Tada H, Wakabayashi H, Verberne HJ.   +6 more
europepmc   +1 more source

The critical role of GRP78/BiP MARylation in ER stress of KRAS-mutant colorectal cancer. [PDF]

JCI Insight
Zhang S, Chen X, Gong Q, Huang J, Tang Y, Xiao M, Li M, Li Q, Wang Y.   +8 more
europepmc   +1 more source

123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations [PDF]

, 2011
Francesc Valldeoriola, Carles Gaig, Africa Muxí, Ignacio Navales, Pilar Paredes, Francisco Lomeña, Andres De la Cerda, Mariateresa Buongiorno, Mario Ezquerra, Pilar Santacruz, Maria Jose Martí, Eduardo Tolosa   +11 more
core   +1 more source

Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Okumura T, Bando YK, Isobe S, Fujita N, Sera F, Ikeda Y, Yajima A, Nagai T, Hiraiwa H, Morimoto R, Anzai T, Node K, Ako J, Sakata Y, Murohara T.   +14 more
europepmc   +1 more source

Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (¹⁸F-Fluoro-L-DOPA-, ⁶⁸Ga-DOTA- and ¹⁸F-Fluoro-Deoxyglucose-Based PET/CT) and of ¹²³I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up. [PDF]

Cancers (Basel)
Scheuba A, Kulterer OC, Lehner R, Rybiczka-Tešulov M, Esterbauer H, Raber W.   +5 more
europepmc   +1 more source

Multicenter development and validation of a probability-based model to diagnose Lewy body disease using ¹²³I-meta-iodobenzylguanidine. [PDF]

Eur J Nucl Med Mol Imaging
Nakajima K, Komatsu J, Matsumura T, Orimo S, Yoshita M, Frantellizzi V, De Feo MS, Greenfinch G, Thomas A, Assante R, Acampa W, Shirasaki N, Yokoyama K, Wakabayashi H, Noguchi-Shinohara M, Ono K, Kinuya S.   +16 more
europepmc   +1 more source

Lesion Analysis of ¹⁸F-Metafluorobenzylguanidine PET Imaging in Neuroblastoma. [PDF]

J Nucl Med
Pandit-Taskar N, Basu E, Pirasteh A, Behr G, Mauguen A, Schwartz J, Lyashchenko S, Vietri S, Burnazi E, Price AP, Modak S.   +10 more
europepmc   +1 more source

[¹²³I]-mIBG and [¹⁸F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma. [PDF]

EJNMMI Rep
Edet-Sanson A, Lechevallier M, Modzelewski R, Becker S, Bouyeure-Petit AC, Bohn P.   +5 more
europepmc   +1 more source